{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:44:12Z","timestamp":1649000652124},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00108-015-3807-8","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T11:42:09Z","timestamp":1453117329000},"page":"38-48","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spezifische Infektionen bei Organtransplantationen"],"prefix":"10.1007","volume":"57","author":[{"given":"M.","family":"Cornberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schlevogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sandherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"3807_CR1","doi-asserted-by":"crossref","unstructured":"Cornberg M, Protzer U, Petersen J et\u00a0al (2011) Prophylaxis, diagnosis and therapy of hepatitis\u00a0B virus infection \u2013 the German guideline. Z\u00a0Gastroenterol 49:871\u2013930","DOI":"10.1055\/s-0031-1273462"},{"key":"3807_CR2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ajg.2013.111","volume":"108","author":"Fung","year":"2013","unstructured":"Fung J, Chan SC, Cheung C et\u00a0al (2013) Oral nucleoside\/nucleotide analogs without hepatitis\u00a0B immune globulin after liver transplantation for hepatitis\u00a0B. Am J Gastroenterol 108:942\u2013948","journal-title":"Am J Gastroenterol"},{"key":"3807_CR3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/tid.12434","volume":"17","author":"Fernandez","year":"2015","unstructured":"Fernandez I, Loinaz C, Hernandez O et\u00a0al (2015) Tenofovir\/entecavir monotherapy after hepatitis\u00a0B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis\u00a0B in liver transplant recipients. Transpl Infect Dis 17:695\u2013701","journal-title":"Transpl Infect Dis"},{"key":"3807_CR4","doi-asserted-by":"crossref","unstructured":"Mederacke I, Filmann N, Yurdaydin C et\u00a0al (2012) Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation. J\u00a0Hepatol 56:115\u2013122","DOI":"10.1016\/j.jhep.2011.06.016"},{"key":"3807_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240\u00a0causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117\u2013171","journal-title":"Lancet"},{"key":"3807_CR6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","volume":"32","author":"Berenguer","year":"2000","unstructured":"Berenguer M, Prieto M, Rayon JM et\u00a0al (2000) Natural history of clinically compensated hepatitis\u00a0C virus-related graft cirrhosis after liver transplantation. Hepatology 32:852\u2013858","journal-title":"Hepatology"},{"key":"3807_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00104-007-1457-7","volume":"79","author":"Schrem","year":"2008","unstructured":"Schrem H, Till N, Becker T et\u00a0al (2008) Long-term results after liver transplantation. Chirurg 79:121\u2013129","journal-title":"Chirurg"},{"key":"3807_CR8","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver (2015) EASL Recommendations on Treatment of Hepatitis\u00a0C 2015. J\u00a0Hepatol 63:199\u2013236","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"3807_CR9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.13343","volume":"42","author":"Deterding","year":"2015","unstructured":"Deterding K, Honer Zu Siederdissen C, Port\u00a0K et\u00a0al (2015) Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies. Aliment Pharmacol Ther 42:889\u2013901","journal-title":"Aliment Pharmacol Ther"},{"key":"3807_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2014.09.023","volume":"148","author":"Curry","year":"2015","unstructured":"Curry MP, Forns X, Chung RT et\u00a0al (2015) Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology 148:100\u2013107.e1","journal-title":"Gastroenterology"},{"key":"3807_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","volume":"149","author":"Charlton","year":"2015","unstructured":"Charlton M, Everson GT, Flamm SL et\u00a0al (2015) Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease. Gastroenterology 149:649\u2013659","journal-title":"Gastroenterology"},{"key":"3807_CR12","doi-asserted-by":"crossref","unstructured":"Kwo PY, Mantry PS, Coakley E et\u00a0al (2014) An interferon-free antiviral regimen for HCV after liver transplantation. N\u00a0Engl J Med 371:2375\u20132382","DOI":"10.1056\/NEJMoa1408921"},{"key":"3807_CR13","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.cgh.2015.05.030","volume":"13","author":"Leroy","year":"2015","unstructured":"Leroy V, Dumortier J, Coilly A et\u00a0al (2015) Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis\u00a0C after liver transplantation. Clin Gastroenterol Hepatol 13:1993\u20132001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3807_CR14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(14)62008-0","volume":"385","author":"Cornberg","year":"2014","unstructured":"Cornberg M, Manns MP (2014) New kids on the block\u2014step by step to an ideal HCV therapy. Lancet 385:1050\u20131052","journal-title":"Lancet"},{"key":"3807_CR15","unstructured":"Roth et\u00a0al. (2015) International Liver Congress"},{"key":"3807_CR16","first-page":"577","volume":"111","author":"Pischke","year":"2014","unstructured":"Pischke S, Behrendt P, Bock CT et\u00a0al (2014) Hepatitis\u00a0E in Germany \u2013 an under-reported infectious disease. Dtsch Arztebl Int 111:577\u2013583","journal-title":"Dtsch Arztebl Int"},{"key":"3807_CR17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","volume":"142","author":"Wedemeyer","year":"2012","unstructured":"Wedemeyer H, Pischke S, Manns MP (2012) Pathogenesis and treatment of hepatitis\u00a0E virus infection. Gastroenterology 142:1388\u20131397.e1","journal-title":"Gastroenterology"},{"key":"3807_CR18","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"384","author":"Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR et\u00a0al (2014) Hepatitis\u00a0E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384:1766\u20131773","journal-title":"Lancet"},{"key":"3807_CR19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","volume":"147","author":"Debing","year":"2014","unstructured":"Debing Y, Gisa A, Dallmeier K et\u00a0al (2014) A mutation in the hepatitis\u00a0E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 147:1008\u20131011.e7","journal-title":"Gastroenterology"},{"key":"3807_CR20","doi-asserted-by":"crossref","unstructured":"Dao Thi VL, Debing Y, Wu X et\u00a0al (2015) Sofosbuvir inhibits hepatitis\u00a0E virus replication in vitro and results in an additive effect when combined with ribavirin. Gastroenterology (im Druck). doi: 10.1053\/j.gastro.2015.09.011","DOI":"10.1053\/j.gastro.2015.09.011"},{"key":"3807_CR21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/TP.0b013e31816651de","volume":"85","author":"Botha","year":"2008","unstructured":"Botha P, Archer L, Anderson RL et\u00a0al (2008) Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 85:771\u2013774","journal-title":"Transplantation"},{"key":"3807_CR22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rmed.2008.11.015","volume":"103","author":"Gottlieb","year":"2009","unstructured":"Gottlieb J, Mattner F, Weissbrodt H et\u00a0al (2009) Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 103:743\u2013749","journal-title":"Respir Med"},{"key":"3807_CR23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/TP.0b013e318182295d","volume":"86","author":"Vos","year":"2008","unstructured":"Vos R, Vanaudenaerde BM, De Vleeschauwer SI et\u00a0al (2008) De novo or persistent pseudomonal airway colonization after lung transplantation: importance for bronchiolitis obliterans syndrome? Transplantation 86:624\u2013625","journal-title":"Transplantation"},{"key":"3807_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000339627","volume":"86","author":"Vital","year":"2013","unstructured":"Vital D, Hofer M, Benden C et\u00a0al (2013) Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration 86:25\u201331","journal-title":"Respiration"},{"key":"3807_CR25","doi-asserted-by":"crossref","unstructured":"Trulock EP, Christie JD, Edwards LB et\u00a0al (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J\u00a0Heart Lung Transplant 26:782\u2013795","DOI":"10.1016\/j.healun.2007.06.003"},{"key":"3807_CR26","doi-asserted-by":"crossref","unstructured":"Christie JD, Edwards LB, Aurora P et\u00a0al (2009) The Registry of the International Society for Heart and Lung Transplantation: twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J\u00a0Heart Lung Transplant 28:1031\u20131049","DOI":"10.1016\/j.healun.2009.08.004"},{"key":"3807_CR27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1600-6143.2004.00483.x","volume":"4","author":"Bowdish","year":"2004","unstructured":"Bowdish ME, Arcasoy SM, Wilt JS et\u00a0al (2004) Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant 4:1171\u20131178","journal-title":"Am J Transplant"},{"key":"3807_CR28","doi-asserted-by":"crossref","unstructured":"Bonvillain RW, Valentine VG, Lombard G et\u00a0al (2007) Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J\u00a0Heart Lung Transplant 26:890\u2013897","DOI":"10.1016\/j.healun.2007.07.002"},{"key":"3807_CR29","unstructured":"o\u00a0A (2011) Cystic Fibrosis Foundation patient registry: annual data report 2010. Cystic Fibrosis Foundation, Bethesda\/MD"},{"key":"3807_CR30","doi-asserted-by":"crossref","unstructured":"Mainz JG, Hentschel J, Schien C et\u00a0al (2012) Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. J\u00a0Cyst Fibros 11:158\u2013161","DOI":"10.1016\/j.jcf.2011.10.009"},{"key":"3807_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0030-1257074","volume":"8","author":"Rademacher","year":"2012","unstructured":"Rademacher J, Welte T (2012) Inhalative Antibiotika \u2013 eine Option f\u00fcr die Zukunft? Intensiv up2date 8:21\u201323","journal-title":"Intensiv up2date"},{"key":"3807_CR32","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","volume":"5","author":"Bohl","year":"2005","unstructured":"Bohl DL, Storch GA, Ryschkewitsch C et\u00a0al (2005) Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5:2213\u20132221","journal-title":"Am J Transplant"},{"key":"3807_CR33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","volume":"5","author":"Brennan","year":"2005","unstructured":"Brennan DC, Agha I, Bohl DL et\u00a0al (2005) Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5:582\u2013594","journal-title":"Am J Transplant"},{"key":"3807_CR34","doi-asserted-by":"crossref","unstructured":"Chou SW (1986) Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N\u00a0Engl J Med 314:1418\u20131423","DOI":"10.1056\/NEJM198605293142205"},{"key":"3807_CR35","doi-asserted-by":"crossref","unstructured":"Crumpacker CS (1996) Ganciclovir. N\u00a0Engl J Med 335:721\u2013729","DOI":"10.1056\/NEJM199609053351007"},{"key":"3807_CR36","doi-asserted-by":"crossref","unstructured":"Dienstag JL (2008) Hepatitis\u00a0B infection. N\u00a0Engl J Med 359:1486\u2013500","DOI":"10.1056\/NEJMra0801644"},{"key":"3807_CR37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ndt\/gfr306","volume":"27","author":"Erdbruegger","year":"2012","unstructured":"Erdbruegger U, Scheffner I, Mengel M et\u00a0al (2012) Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transplant 27:435\u2013443","journal-title":"Nephrol Dial Transplant"},{"key":"3807_CR38","doi-asserted-by":"crossref","unstructured":"Fischer SA, Graham MB, Kuehnert MJ et\u00a0al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N\u00a0Engl J Med 354:2235\u20132249","DOI":"10.1056\/NEJMoa053240"},{"key":"3807_CR39","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1600-6143.2010.03225.x","volume":"10","author":"Helanter\u00e4","year":"2010","unstructured":"Helanter\u00e4 I, Kyll\u00f6nen L, Lautenschlager I et\u00a0al (2010) Primary CMV infections are commen in kidney transplant recipients after 6\u00a0months valgancyclovir prophylaxis. Am J Transplant 10:2026\u20132032","journal-title":"Am J Transplant"},{"key":"3807_CR40","doi-asserted-by":"crossref","unstructured":"Hirsch HH, Knowles W, Dickenmann M et\u00a0al (2002) Prospective study of polyomavirus type\u00a0BK replication and nephropathy in renal-transplant recipients. N\u00a0Engl J Med 347:488\u2013496","DOI":"10.1056\/NEJMoa020439"},{"key":"3807_CR41","doi-asserted-by":"crossref","unstructured":"Iwarmoto M, Jernigan DB, Guasch A et\u00a0al (2003) Transmission of West Nile Virus from an organ donor to four transplant recipients. N\u00a0Engl J Med 348:2196\u20132203","DOI":"10.1056\/NEJMoa022987"},{"key":"3807_CR42","doi-asserted-by":"crossref","unstructured":"Kamar N, Selves J, Mansuy JM et\u00a0al (2008) Hepatitia\u00a0E virus and chronic hepatitis in organ transplant patients. N\u00a0Engl J Med 358:811\u2013817","DOI":"10.1056\/NEJMoa0706992"},{"key":"3807_CR43","doi-asserted-by":"crossref","unstructured":"Pereira BJG, Milford EL, Kirkman RL et\u00a0al (1991) Transmission of hepatitis\u00a0C virus by organ transplantation. N\u00a0Engl J Med 325:454\u2013460","DOI":"10.1056\/NEJM199108153250702"},{"key":"3807_CR44","first-page":"35","volume":"111","author":"Pischke","year":"2014","unstructured":"Pischke S, Behrendt P, Bock C et\u00a0al (2014) Hepatitis\u00a0E in Germany; an under-reported infectious disease. Dtsch Arztebl Int 111:35\u201336","journal-title":"Dtsch Arztebl Int"},{"key":"3807_CR45","first-page":"1103","volume":"Transplant","author":"Preiksaitis","year":"2004","unstructured":"Preiksaitis JK, Green M, Avery RK (2004) Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant (Suppl\u00a010):1103\u20131011","journal-title":"Am J"},{"key":"3807_CR46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0272-6386(95)90608-8","volume":"26","author":"Purighalla","year":"1995","unstructured":"Purighalla R, Shapiro R, McCauley J et\u00a0al (1995) BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 26:671\u2013673","journal-title":"Am J Kidney Dis"},{"key":"3807_CR47","doi-asserted-by":"crossref","unstructured":"Reischig T, Hribova P, Jindra P et\u00a0al (2012) Long-term outcomes of pre-emptive valgancyclovir compared with valgancyclovir prophylaxis for prevention of CMV in renal transplantation. J\u00a0Am Soc Nephrol 23:1588\u20131597","DOI":"10.1681\/ASN.2012010100"},{"key":"3807_CR48","first-page":"636","volume":"305","author":"Ross","year":"2015","unstructured":"Ross RS, Wolters B, Hoffmann B et\u00a0al (2015) Instructive even after a decade: complete results of initial virological diagnostics and re-evaluation of molecular data in the German rabies virus \u201eoutbreak\u201c caused by transplantation. Int J Microbiol 305:636\u2013643","journal-title":"Int J Microbiol"},{"key":"3807_CR49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000189444","volume":"74","author":"Rostaing","year":"1996","unstructured":"Rostaing L, Modesto A, Baron E et\u00a0al (1996) Acute renal failure in kidney transplant patients treated with interferone alpha\u00a02b for chronic hepatitis\u00a0C. Nephron 74:512\u2013516","journal-title":"Nephron"},{"key":"3807_CR50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007890-198707000-00006","volume":"44","author":"Schwarz","year":"1987","unstructured":"Schwarz A, Hoffmann F, L\u2019age-Stehr J et\u00a0al (1987) Human immunodeficiency virus transsmission by organ donation. Transplantation 44:21\u201324","journal-title":"Transplantation"},{"key":"3807_CR51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TP.0b013e31825a505d","volume":"94","author":"Schwarz","year":"2012","unstructured":"Schwarz A, Linnenweber-Held S, Heim A (2012) Factors influencing viral clearing and renal function during polyomavirus\u00a0BK-associated nephropathy after renal transplantation. Transplantation 94:396\u2013402","journal-title":"Transplantation"},{"key":"3807_CR52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11560-014-0911-z","volume":"10","author":"Schwarz","year":"2015","unstructured":"Schwarz A (2015) Hepatitis\u00a0C und Nierentransplantation. Nephrologe 10:107\u2013112","journal-title":"Nephrologe"},{"key":"3807_CR53","doi-asserted-by":"crossref","unstructured":"Schwarz A, Linnenweber-Held S, Heim A et\u00a0al (2015) Viral origin, clinical course and renal outcomes in patients with BK\u00a0virus infection after living-donor renal transplantation. Transplantation (im Druck)","DOI":"10.1097\/TP.0000000000001066"},{"key":"3807_CR54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","volume":"93","author":"Witzke","year":"2012","unstructured":"Witzke O, Hauser IA, Bartels M et\u00a0al (2012) Valgancyclovir prophylaxis versus preemptive therapy in CMV-positive renal allograft recipients: 1-year results of a randomized clinical trial. Transplantation 93:61\u201368","journal-title":"Transplantation"},{"key":"3807_CR55","first-page":"CR609","volume":"17","author":"Van","year":"2011","unstructured":"Van Ree RM, Vries APJ de, Zelle DM et\u00a0al (2011) Latent CMV infection is an independent risk factor for late graft failure in renal transplant recipients. Med Sci Monit 17:CR609\u2013CR617","journal-title":"Med Sci Monit"},{"key":"3807_CR56","doi-asserted-by":"crossref","unstructured":"Whitley RJ, Gnann JW (1992) Acyclovir: A decade later. N\u00a0Engl J Med 327:782\u2013789","DOI":"10.1056\/NEJM199209103271108"},{"key":"3807_CR57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-91-3-412","volume":"91","author":"Wolf","year":"1979","unstructured":"Wolf JL, Perkins HA, Schroeder MT et\u00a0al (1979) The transplanted kidney as a source of hepatitis\u00a0B infection. Ann Intern Med 91:412\u2013414","journal-title":"Ann Intern Med"},{"key":"3807_CR58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12660","volume":"20","author":"Gavalda","year":"2014","unstructured":"Gavalda J, Meije Y, Fortun J et\u00a0al (2014) Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 20(Suppl\u00a07):27\u201348","journal-title":"Clin Microbiol Infect"},{"key":"3807_CR59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","volume":"13","author":"Singh","year":"2013","unstructured":"Singh NM, Husain S, AST Infectious Diseases Community of Practice (2013) Aspergillosis in solid organ transplantation. Am J Transplant 13:228\u2013241","journal-title":"Am J Transplant"},{"key":"3807_CR60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","volume":"15","author":"Neofytos","year":"2013","unstructured":"Neofytos D, Treadway S, Ostrander D et\u00a0al (2013) Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single center experience. Transpl Infect Dis 15(3):233\u2013242","journal-title":"Transpl Infect Dis"},{"key":"3807_CR61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/lt.24032","volume":"21","author":"Barchiesi","year":"2015","unstructured":"Barchiesi F, Mazzocato S, Mazzanti S et\u00a0al (2015) Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116\u00a0cases. Liver Transpl 21:204\u2013212","journal-title":"Liver Transpl"},{"key":"3807_CR62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/tid.12301","volume":"16","author":"Hoyo","year":"2014","unstructured":"Hoyo I, Sanclemente G, Puig de la Bellacasa J (2014) Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients. Transpl Infect Dis 16:951\u2013957","journal-title":"Transpl Infect Dis"},{"key":"3807_CR63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","volume":"50","author":"Pappas","year":"2010","unstructured":"Pappas PG, Alexander BD, Andes DR et\u00a0al (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50:1101\u20131111","journal-title":"Clin Infect Dis"},{"key":"3807_CR64","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","volume":"50","author":"Baddley","year":"2010","unstructured":"Baddley JW, Andes DR, Marr KA et\u00a0al (2010) Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 50:1559\u20131567","journal-title":"Clin Infect Dis"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3807-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-015-3807-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3807-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:17:43Z","timestamp":1558570663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-015-3807-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1007\/s00108-015-3807-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}